Next Article in Journal
Previous Article in Journal
Int. J. Mol. Sci. 2011, 12(3), 1744-1755; doi:10.3390/ijms12031744
Article

Experimental Construction of BMP2 and VEGF Gene Modified Tissue Engineering Bone in Vitro

1
, 2
 and 2,*
Received: 31 December 2010; in revised form: 22 February 2011 / Accepted: 1 March 2011 / Published: 7 March 2011
(This article belongs to the Section Material Sciences and Nanotechnology)
View Full-Text   |   Download PDF [500 KB, uploaded 19 June 2014]
Abstract: The purpose of this study was to investigate the feasibility and advantages of constructing a novel tissue engineering bone, using β-tricalcium phosphate (β-TCP) and rat bone marrow mesenchymal stem cells (MSCs), modified with human bone morphogenetic protein 2 gene (hBMP2) and human vascular endothelial growth factor 165 gene (hVEGF165), through lentiviral transfection. Both genes were successfully co-expressed in the co-transfection group for up to eight weeks confirmed by enzyme-linked immunosorbent assay (ELISA). After seeding MSCs onto the scaffolds, scanning electron microscopy (SEM) observation showed that MSCs grew and proliferated well in co-transfection group at 7 and 14 days. There was no significant difference among all the groups in hoechst DNA assay for cell proliferation for 14 days after cell seeding (P > 0.05), but the highest alkaline phosphatase (ALP) activity was observed in the co-transfection group at 14 days after cell seeding (p < 0.01). These results demonstrated that it was advantageous to construct tissue engineering bone using β-TCP combined with MSCs lentivirally co-transfected with BMP2 and VEGF165, providing an innovative way for treating bone defects.
Keywords: bone morphogenetic protein 2; co-transfection; lentiviral vector; tissue engineering bone; vascular endothelial growth factor; β-tricalcium phosphate (β-TCP) bone morphogenetic protein 2; co-transfection; lentiviral vector; tissue engineering bone; vascular endothelial growth factor; β-tricalcium phosphate (β-TCP)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Jiang, J.; Fan, C.-Y.; Zeng, B.-F. Experimental Construction of BMP2 and VEGF Gene Modified Tissue Engineering Bone in Vitro. Int. J. Mol. Sci. 2011, 12, 1744-1755.

AMA Style

Jiang J, Fan C-Y, Zeng B-F. Experimental Construction of BMP2 and VEGF Gene Modified Tissue Engineering Bone in Vitro. International Journal of Molecular Sciences. 2011; 12(3):1744-1755.

Chicago/Turabian Style

Jiang, Jia; Fan, Cun-Yi; Zeng, Bing-Fang. 2011. "Experimental Construction of BMP2 and VEGF Gene Modified Tissue Engineering Bone in Vitro." Int. J. Mol. Sci. 12, no. 3: 1744-1755.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert